[Effect of thymagen, thymalin and vilosen on the cAMP and cGMP levels and phosphodiesterase activity in spleen lymphocytes during sensitization and anaphylactic shock].
Demidov. S V SV; Kostromin. A N AN; Kuĭbeda. V V VV; Chernaia. I V IV; Borovok. M I MI
Key Findings
- Sensitization lowers the cAMP/cGMP ratio in spleen lymphocytes.
- Thymalin (along with thymogen and vilosen) raises phosphodiesterase activity, speeding up breakdown of cyclic nucleotides in sensitized animals.
- During anaphylactic shock the cAMP/cGMP ratio normalizes, and thymalin tends to further increase enzyme activity.
Practical Outcomes
- For most biohackers this research offers limited direct use. It suggests thymalin might influence immune signaling during allergic events, but without human data or dosage guidance it isn’t ready for practical longevity or performance protocols.
Summary
The study shows that thymalin, a thymus‑derived peptide, can change the balance of cellular signaling molecules (cAMP and cGMP) and boost the enzymes that break them down in immune cells of guinea pigs during allergic reactions, but it’s an animal experiment with no human dosing or clear health‑boosting protocol.
Abstract
It is established that the effect of thymus-derived species is connected with the cyclic nucleotide system. The action of thymus-derived immunocorrectors (thymalin, thymagen, vilosen) on catabolic processes of cyclic nucleotides has been observed under conditions of anaphylaxy and sensibilization. They show that sensibilization of the animal is bound up with a decrease of the cAMP/cGMP ratio. Anaphylaxis induces levelling of the cAMP/cGMP ratio up to the reference level. So, activity of enzymes of cyclic nucleotide catabolism grows due to the influence of thymogen, thymalin and vilosen in lymphocytes of sensibilized guinea pigs and tends to an increase in lymphocytes of anaphylaxis-treated animals.
Study Information
pubmed
1991